TY  - JOUR 
AU  - Valladares Ayerbes, Manuel
PY  - 2015
SN  - 0344-5704
UR  - http://hdl.handle.net/20.500.11940/3911
LA  - eng
TI  - Phase II trial of miniDOX (reduced dose docetaxel-oxaliplatin-capecitabine) in
DO  - 10.1007/s00280-014-2641-3
T2  - CANCER CHEMOTHERAPY AND PHARMACOLOGY
M2  - 319
VL  - 75
ER  -